Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: Comparison with its single-chain analog
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
1970 • 253,849 citations
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
1986 • 6,284 citations
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay
1973 • 3,279 citations
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
1988 • 1,536 citations
Single-Chain Antigen-Binding Proteins
1988 • 1,450 citations
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
1981 • 1,366 citations
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
1992 • 824 citations
A comparison of strategies to stabilize immunoglobulin Fv-fragments
1990 • 469 citations
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
1989 • 420 citations
A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies
1992 • 343 citations
Recombinant Toxins for Cancer Treatment
1991 • 308 citations
An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
1993 • 289 citations
The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA
1985 • 247 citations
A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
1993 • 226 citations
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
1990 • 150 citations
Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli
1991 • 145 citations
Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas.
1991 • 140 citations
Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma
1994 • 137 citations
Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions
1994 • 128 citations
Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv
1994 • 113 citations
Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells.
1990 • 94 citations
Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials.
1990 • 72 citations
[IMMUNITY TO CANCER].
1964 • 46 citations
Pharmacokinetic considerations on monoclonal antibodies.
1989 • 27 citations
Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy
1993 • 20 citations
The coming of age of cancer radioimmunoconjugates
1993 • 19 citations
Radioantibodies for the Diagnosis and Treatment of Cancer; Radioimmunoimaging (RAI) and Radioimmunotherapy (RAT)
1990 • 8 citations